Prediction of improvement in schizophrenia under four phenothiazines.

Suppr

超能文献

作者信息

Goldberg S C, Mattsson N, Cole J O, Klerman G L

出版信息

Arch Gen Psychiatry. 1967 Jan;16(1):107-17. doi: 10.1001/archpsyc.1967.01730190109015.

DOI:10.1001/archpsyc.1967.01730190109015

PMID:6066689

Abstract

摘要

相似文献

Prediction of improvement in schizophrenia under four phenothiazines.

Arch Gen Psychiatry. 1967 Jan;16(1):107-17. doi: 10.1001/archpsyc.1967.01730190109015.

Schizophrenic subtypes defined by response to drugs and placebo.

Dis Nerv Syst. 1968 May;29(5):Suppl:153-8.

Dyskinesia and neuroleptics.

Arch Gen Psychiatry. 1968 Dec;19(6):700-3. doi: 10.1001/archpsyc.1968.01740120060009.

Life history and symptoms in schizophrenia. Severity at hospitalization and response to phenothiazines.

Arch Gen Psychiatry. 1971 Aug;25(2):138-47. doi: 10.1001/archpsyc.1971.01750140042008.

Specific indications for different classes of phenothiazines.

Arch Gen Psychiatry. 1974 Jan;30(1):94-9. doi: 10.1001/archpsyc.1974.01760070072011.

Paranoid and withdrawal symptoms in schizophrenia: differential symptom reduction over time.

J Nerv Ment Dis. 1967 Aug;145(2):158-62. doi: 10.1097/00005053-196708000-00008.

[ECG picture in the course of treatment of schizophrenia with phenothiazine derivatives].

Psychiatr Pol. 1971 Jan-Feb;5(1):49-54.

Differences in clinical effects of three phenothiazines in "acute" schizophrenia.

Dis Nerv Syst. 1967 Jun;28(6):369-83.

The comparative effectiveness of eight phenothiazines.

Psychopharmacologia. 1965 Feb 15;7(2):89-106. doi: 10.1007/BF00403632.

[Differential indication for the use of neuroleptics].

Act Nerv Super (Praha). 1970 Jan 12;12(1):1-11.

引用本文的文献

Fluphenazine (oral) versus placebo for schizophrenia.

Cochrane Database Syst Rev. 2018 Jun 12;6(6):CD006352. doi: 10.1002/14651858.CD006352.pub3.

Fluphenazine decanoate (depot) and enanthate for schizophrenia.

Cochrane Database Syst Rev. 2015 Feb 5;2015(2):CD000307. doi: 10.1002/14651858.CD000307.pub2.

Fluphenazine (oral) versus placebo for schizophrenia.

Cochrane Database Syst Rev. 2013 Jul 17;7(7):CD006352. doi: 10.1002/14651858.CD006352.pub2.

Antipsychotic medication for early episode schizophrenia.

Cochrane Database Syst Rev. 2011 Jun 15;2011(6):CD006374. doi: 10.1002/14651858.CD006374.pub2.

Thioridazine for schizophrenia.

Cochrane Database Syst Rev. 2007 Jul 18;2007(3):CD001944. doi: 10.1002/14651858.CD001944.pub2.

Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry.

Br Med J. 1973 Mar 17;1(5854):633-7. doi: 10.1136/bmj.1.5854.633.

Efficacy of loxapine in the treatment of paranoid schizophrenia.

Psychopharmacology (Berl). 1977 Jan 31;51(2):107-15. doi: 10.1007/BF00431725.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Prediction of improvement in schizophrenia under four phenothiazines.

Arch Gen Psychiatry. 1967 Jan;16(1):107-17. doi: 10.1001/archpsyc.1967.01730190109015.

Schizophrenic subtypes defined by response to drugs and placebo.

Dis Nerv Syst. 1968 May;29(5):Suppl:153-8.

Dyskinesia and neuroleptics.

Arch Gen Psychiatry. 1968 Dec;19(6):700-3. doi: 10.1001/archpsyc.1968.01740120060009.

Life history and symptoms in schizophrenia. Severity at hospitalization and response to phenothiazines.

Arch Gen Psychiatry. 1971 Aug;25(2):138-47. doi: 10.1001/archpsyc.1971.01750140042008.

Specific indications for different classes of phenothiazines.

Arch Gen Psychiatry. 1974 Jan;30(1):94-9. doi: 10.1001/archpsyc.1974.01760070072011.

Paranoid and withdrawal symptoms in schizophrenia: differential symptom reduction over time.

J Nerv Ment Dis. 1967 Aug;145(2):158-62. doi: 10.1097/00005053-196708000-00008.

[ECG picture in the course of treatment of schizophrenia with phenothiazine derivatives].

Psychiatr Pol. 1971 Jan-Feb;5(1):49-54.

Differences in clinical effects of three phenothiazines in "acute" schizophrenia.

Dis Nerv Syst. 1967 Jun;28(6):369-83.

The comparative effectiveness of eight phenothiazines.

Psychopharmacologia. 1965 Feb 15;7(2):89-106. doi: 10.1007/BF00403632.

[Differential indication for the use of neuroleptics].

Act Nerv Super (Praha). 1970 Jan 12;12(1):1-11.

引用本文的文献

Fluphenazine (oral) versus placebo for schizophrenia.

Cochrane Database Syst Rev. 2018 Jun 12;6(6):CD006352. doi: 10.1002/14651858.CD006352.pub3.

Fluphenazine decanoate (depot) and enanthate for schizophrenia.

Cochrane Database Syst Rev. 2015 Feb 5;2015(2):CD000307. doi: 10.1002/14651858.CD000307.pub2.

Fluphenazine (oral) versus placebo for schizophrenia.

Cochrane Database Syst Rev. 2013 Jul 17;7(7):CD006352. doi: 10.1002/14651858.CD006352.pub2.

Antipsychotic medication for early episode schizophrenia.

Cochrane Database Syst Rev. 2011 Jun 15;2011(6):CD006374. doi: 10.1002/14651858.CD006374.pub2.

Thioridazine for schizophrenia.

Cochrane Database Syst Rev. 2007 Jul 18;2007(3):CD001944. doi: 10.1002/14651858.CD001944.pub2.

Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry.

Br Med J. 1973 Mar 17;1(5854):633-7. doi: 10.1136/bmj.1.5854.633.

Efficacy of loxapine in the treatment of paranoid schizophrenia.

Psychopharmacology (Berl). 1977 Jan 31;51(2):107-15. doi: 10.1007/BF00431725.